Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report

Eur J Clin Pharmacol. 2022 May;78(5):891-893. doi: 10.1007/s00228-022-03294-2. Epub 2022 Feb 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / therapeutic use
  • Antirheumatic Agents*
  • Etanercept / therapeutic use
  • Humans
  • Infliximab / therapeutic use
  • Tumor Necrosis Factor-alpha

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab
  • Etanercept